| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $4.00 | $5.82 | — | — | — | — | — | — |
| EPS (Diluted) | $4.00 | $5.82 | — | — | — | — | — | — |
| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.6B | $5.0B | $5.2B | $4.6B | $4.0B | $3.0B | $3.0B | $3.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $5.0B | $4.5B | $4.6B | $4.0B | $3.5B | $2.6B | $2.6B | $2.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B | $0.4B | $0.4B | $0.4B |
| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | — | — | — |
| Investing Cash Flow | $-0.1B | $-0.4B | $-0.3B | $-0.0B | $-0.0B | — | — | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $-0.1B | $0.3B | $0.5B | $0.0B | — | — | — |